BRD2 and osteoporosis: More recently, paralleling increased circulating levels of FSH occurring at menopause, FSH/FSHR have been reported to likely play a role in highly prevalent pathologies such as obesity, osteoporosis, cardiovascular diseases [11], or Alzheimer’s disease [12,13].